OneVentures
Team Portfolio Funds Entrepreneurs Blog News Investors
TeamPortfolioFundsEntrepreneursBlogNewsInvestors
OneVentures

High-density microarray patch could provide alternative to syringe vaccine delivery

 

Read more from the European Pharmaceutical Review below.

Learn more
 
EPRCarolyn MillerMarch 25, 2020Vaxxas, Paul Kelly
Twitter LinkedIn0 0 Likes
Previous

Clinical Genomics expands strategic relationship with Quest Diagnostics and further increases momentum for innovative first-line colorectal cancer screening blood test

Media ReleaseCarolyn MillerApril 30, 2020Clinical Genomics, Paul Kelly
Next

Queensland researchers develop ‘vaccination patch’, backed by Bill Gates’ foundation

Carolyn MillerMarch 19, 2020Vaxxas, Paul Kelly

Suite 13.02, 179 Elizabeth Street, Sydney NSW 2000

enquiries@one-ventures.com

+61 2 8205 7379

Disclaimer

Responsible Investment Policy

Privacy Policy

 
 
OneVentures Pty Ltd
179 Elizabeth Street (Suite 13.02),
Sydney, NSW, 2000,
Australia
+61 2 8205 7379 enquiries@one-ventures.com
Hours

Copyright © 2017 OneVentures Pty Ltd